Dr. Scott Daniel Caganap, MD

Dr. Caganap practices at Providence Little Company of Mary Medical Center Torrance in Torrance, California, part of Providence Health & Services.

Dr. Caganap's NPI, 1962845073, was assigned on April 9, 2013. Dr. Caganap graduated from Drexel University College Of Medicine in 2013. Dr. Caganap holds California license A134843.

Dr. Caganap's primary practice is Providence Little Company of Mary Medical Center Torrance, at 4101 Torrance Blvd, Torrance, CA 90503 in Los Angeles County. The practice phone is (310) 540-7676.

Dr. Caganap's primary practice is Providence Little Company of Mary Medical Center Torrance in Torrance, California, part of Providence Health & Services. Dr. Caganap is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Facey Medical Group. Dmand AI also links Dr. Caganap to 4 more hospitals, 13 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Caganap practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Caganap's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Caganap is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Caganap's licenses on file in 15 states: California, Colorado, Alaska, Iowa, Illinois, Missouri, Idaho, Kansas, Montana, Nevada, Ohio, Oregon, Wisconsin, Wyoming and Utah.

Dmand AI lists cerebrovascular disease, epilepsy and sleep apnea among the conditions Dr. Caganap treats.

CMS data shows 455 Medicare services from Dr. Caganap across 3 procedure codes in 2024, for 265 Medicare patients. Medicare paid $60,335 for them.

CMS counts 265 Medicare patients who saw Dr. Caganap in 2024. The largest group is 75 to 84, with 92 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Caganap's median patient age at 65, with 50% women.

In 2017, Dr. Caganap wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $346 in total drug cost. In 2016, CMS named 63 claims across 5 drugs.

Dr. Caganap accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Caganap as offering telehealth.

Dmand AI links 2 papers to Dr. Caganap in 2025. Dr. Caganap's most frequent co-authors are John Alexander Brooks, MD, Frcp(c), Barry Michael Czeisler, MD and Raquel Farias-Moeller, MD.

CMS Open Payments shows 2 general payments to Dr. Caganap from 2 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 69% of the total. Biogen, Inc. paid the most, $48.

Dmand AI lists 9 awards for Dr. Caganap, most recently Alpha Omega Alpha in 2013.

Dr. Caganap graduated from Drexel University College Of Medicine in 2013.

Dr. Caganap is in network with 22 carriers, including Aetna, Elevance and HCSC. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.